HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Lichenoid eruptions after gold therapy. Report of two cases].

Abstract
Lichenoid eruptions appearing in two women receiving chrysotherapy (Solganal B oleosum R) a described. The morphological diagnosis, distribution of skin eruptions, histological and immunological features and monoclonal antibodies (Leu 4, Leu 2A and Leu 3A) against several cell surface markers were studied. Individual lesions were not distinguishable from idiopathic lichen planus, with some features typical for gold lichenoid eruptions: hyperpigmentation, psoriasiform eruptions, and hair loss. Histopathological and immunological examination of biopsy specimens with monoclonal antibodies generally confirms clinical impressions. The authors suggest similar pathogenetic mechanisms in the development of idiopathic lichen planus and of lichenoid eruptions after gold therapy.
AuthorsA Z Lasarowa, N K Tsankov, A P Stoimenov
JournalDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete (Hautarzt) Vol. 43 Issue 8 Pg. 514-6 (Aug 1992) ISSN: 0017-8470 [Print] Germany
Vernacular TitleLichenoide Eruptionen nach Goldtherapie. Bericht über zwei Fälle.
PMID1387122 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Aurothioglucose
Topics
  • Adult
  • Aged
  • Arthritis, Rheumatoid (drug therapy)
  • Atrophy
  • Aurothioglucose (administration & dosage, adverse effects)
  • Drug Eruptions (pathology)
  • Female
  • Fluorescent Antibody Technique
  • Humans
  • Lichen Planus (chemically induced, pathology)
  • Skin (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: